Thurston, Springer, Miller, Herd & Titak, Inc. Emergent Bio Solutions Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $730 Million
- Q2 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 22 shares of EBS stock, worth $196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22
Previous 22
-0.0%
Holding current value
$196
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EBS
# of Institutions
184Shares Held
41.1MCall Options Held
143KPut Options Held
168K-
Black Rock Inc. New York, NY3.84MShares$34.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.58MShares$31.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$22.3 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.29MShares$20.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.85MShares$16.5 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $444M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...